ATAI also has VLS-01, which gives it a nearer-term Q4 2026 TRD catalyst. EMP-01 adds some optionality in social anxiety ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...
Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...
PARP inhibitors reshaped oncology when they first reached patients some 10 years ago, but they represent just one entry point into a much larger and more intricate biological network.
Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) ("Biodexa” or the "Company”), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with ...
The ambitious overhaul places uncrewed platforms at the center of future UK forces operations on land, at sea, and in the air ...
Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...
AP-101 is an investigational human-derived antibody that selectively targets the misfolded, toxic form of superoxide dismutase 1 (SOD1) to disrupt the progressive spread of ALS. The goal of this ...
BingX Partners with Save the Children to Support Children at Risk in Western Balkans The new partnership will support migrant ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing ...
Isaacman will announce the next round of lunar lander mission awards Tuesday at 2:30 p.m. ET, as Blue Origin rebuilds its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results